Fresenius Kabi
Patrick O'Connor, MBA, has a diverse background in sales and account management across multiple industries. Currently serving as an IV Portfolio Account Executive for Fresenius Kabi in the Northeast US, Patrick previously held positions at Outset Medical, Inc. as a Tablo® Hemodialysis System Clinical Sales representative and at Baxter International Inc. in various roles, including Pharmacy Sales Specialist and Inside IV Portfolio Territory Manager. Earlier experience includes working as a Logistics Account Executive at Total Quality Logistics and as a Management Trainee at Enterprise Holdings, LLC. Patrick holds a Master of Business Administration from The Ohio State University Fisher College of Business and a degree in Political Science from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.